Drug Pipeline

Losartan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
14
Active Studies
8
Recruiting
10
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT03900793
Losartan + Sunitinib in Treatment of Osteosarcoma
date change Primary completion pushed: 2026-08 -> 2027-08-01
2026-06-12 NCT03900793
Losartan + Sunitinib in Treatment of Osteosarcoma
date change Completion pushed: 2027-02 -> 2029-08-01
Active Studies by Phase
Phase 4
1
Phase 2
7
Phase 1
4
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07547878 Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Chronic Kidney Disease Not Yet Recruiting
Phase 2
NCT06933706 Losartan to Improve Outcomes After Multi-ligament Knee Injury Multi-ligament Knee Injury Recruiting
NCT05012631 Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease Sickle Cell Disease Recruiting
NCT05637216 Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients Radiation Induced Fibrosis Recruiting
NCT02560805 Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV Stress Disorders, Post-Traumatic Recruiting
NCT04539808 NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery… Pancreatic Adenocarcinoma Active, Not Recruiting
NCT05077800 FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer Pancreatic Adenocarcinoma Active, Not Recruiting
NCT07265739 Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer Platinum Resistant Ovarian Cancer Not Yet Recruiting
Phase 1
NCT06211335 Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of… Locally Recurrent Head and Neck Squamous Cell Carcinoma Recruiting
NCT07300670 The Effect of Losartan on Cephalexin Possible Interaction Between Losartan and Cephalexin Recruiting
NCT03900793 Losartan + Sunitinib in Treatment of Osteosarcoma Osteosarcoma Recruiting
NCT04106856 Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally… Borderline Resectable Pancreatic Adenocarcinoma Active, Not Recruiting
Not specified
NCT07513350 Investigation of the Effectiveness of Exercise and Anti-Fibrotic Approaches in Frozen… Adhesive Capsulitis of Shoulder Recruiting
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
Sponsors Running Losartan Trials
Disease Areas
Get alerts when Losartan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free